Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Katarzyna Bogucka-JancziFederico MariniSebastian RosigkeitJanine SchloederHelmut JonuleitKerstin DavidMargarita SchlackowKrishnaraj RajalingamPublished in: Cancer gene therapy (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Keyphrases